Request Discount

Blepharitis Drugs Market (Type - Anterior Blepharitis, and Posterior Blepharitis; Treatment Type - Warm Compresses or Eyelid Scrubs, Mechanical Glandular Eyelid Massage, Artificial Lubricants, Topical Antibiotics, Topical Corticosteroids, Combination Topical Corticosteroids and Antibiotic, Meibomian Gland Expression, Oral Antibiotics, and Dietary Supplements; Dosage Form - Tablets, Solution, Suspension, Ointment, and Others; Route of Administration - Oral, and Topical; End- users - Hospitals, Homecare, Specialty Clinics, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2026

  • Published : August, 2020

  • Rep Id : HC0866

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on the blepharitis drugs market provides an in-depth analysis of segments and sub-segments in the global as well as regional blepharitis drugs market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional blepharitis drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast, and dollar values of the global blepharitis drugs market. According to the report, the global blepharitis drugs market is projected to grow at a healthy CAGR over the forecast period of 2020-2026.

 

Market Insight

Blepharitis is a chronic disorder that causes inflammation of the eyelids. The rising population of blepharitis across the globe and the emergence of drugs used in the treatment of risk related to blepharitis such as blepharoconjunctivitis, hordeolum, and chalazion (Styes) are the key factors to boost the market growth. Additionally, the current concern over the spread of coronavirus is also projected to have a negative impact on the blepharitis drugs market for the short term. Numerous countries, comprising major pharmaceutical industry, have initiated lockdowns and enforced nationwide travel and trade restrictions. The main factors expected to exert an impact on the blepharitis drugs market include delay in outpatient hospital visits for non-urgent treatments, reduced pharmaceutical spending, and delay in approval and launch of new drugs, and supply chain disruptions worldwide. On the other hand, the impact is somewhat being neutralized by the shift of healthcare providers and patients towards teleconsultation and telemedicine and has led to an increase in the number of virtual visits internationally.

 

The global blepharitis drugs market is primarily driven by increasing prevalence of ophthalmological disorders, such as dry eye, uveitis among others. Furthermore, factors such as growing demand for advanced treatment, government initiatives, rising awareness among mass regarding eye care, and increasing market players offering newer products for the treatment of blepharitis are likely to propel the market growth. Moreover, the involvement of leading players in new product development and enhancing their existing products to increase their product portfolio is heightening the growth of the global blepharitis drugs market. In addition, the usage of a combination of off-label steroids and antibiotics is growing to treat blepharitis because of the deficiency of availability of approved therapies and their proven advantages over monotherapy. Consequently, vendors are recording increased sales, which will contribute to the growth of the blepharitis drug market over the projection period. Conversely, the development of novel treatment procedures, antimicrobial resistance, and a dearth of approved therapies to treat blepharitis may hinder the growth of the blepharitis drugs market in the near future.

 

Among the geographies, North America region is expected to hold the largest share in the global blepharitis drugs market owing to a surge in funding for the development of research and health care infrastructure. Further, factors such as an increase in the incidence of ocular diseases such as blepharitis and early phase diagnosis and treatment of diseases are driving the biotechnology & pharmaceutical division in the region, which, in turn, is anticipated to propel the blepharitis drugs market in North America region. Furthermore, the Asia Pacific region is projected to witness the the fastest growth in the blepharitis drugs market during the forecast period owing to the rising prevalence of eye disorders. In addition, the rising awareness about the health and increasing demand for healthcare facilities in emerging economies such as China and India drive the market in this region.

 

Segment Covered

The report on global blepharitis drugs market covers segments such as type, treatment type, dosage form, route of administration, and end- users. On the basis of type, the sub-markets include anterior blepharitis, and posterior blepharitis. On the basis of treatment type, the sub-markets include warm compresses or eyelid scrubs, mechanical glandular eyelid massage, artificial lubricants, topical antibiotics, topical corticosteroids, combination topical corticosteroids and antibiotic, meibomian gland expression, oral antibiotics, and dietary supplements. On the basis of dosage form, the sub-markets include tablets, solution, suspension, ointment, and others. On the basis of route of administration, the sub-markets include oral, and topical. On the basis of end- users, the sub-markets include hospitals, homecare, specialty clinics, and others.

 

Companies Profiled:

The report provides profiles of the companies in the market such as AbbVie Inc., Amgen Inc, Celgene Corporation, Pfizer Inc., Biogen, Novartis AG, Johnson & Johnson Services, Inc., Merck & Co., Inc., Regeneron Pharmaceuticals Inc., and Gilead Sciences, Inc.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the blepharitis drugs market. Moreover, the study highlights current market trends and provides forecast from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount